|
ASND
|
Ascendis Pharma A/S
|
US
|
NASDAQ
|
|
ATHE
|
Alterity Therapeutics Limited
|
US
|
NASDAQ
|
|
ATHX
|
Athersys, Inc.
|
US
|
NASDAQ
|
|
ATNF
|
180 Life Sciences Corp.
|
US
|
NASDAQ
|
|
ATXS
|
Astria Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AURA
|
Aura Biosciences, Inc.
|
US
|
NASDAQ
|
|
AUTL
|
Autolus Therapeutics plc
|
US
|
NASDAQ
|
|
AVRO
|
AVROBIO, Inc.
|
US
|
NASDAQ
|
|
AXLA
|
Axcella Health Inc.
|
US
|
NASDAQ
|
|
AYLA
|
Ayala Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AZYO
|
Aziyo Biologics, Inc.
|
US
|
NASDAQ
|
|
BAD
|
B.A.D. ETF
|
US
|
AMEX
|
|
BBC
|
Virtus LifeSci Biotech Clinical Trials ETF
|
US
|
AMEX
|
|
BBH
|
Market Vectors Biotech ETF
|
US
|
NASDAQ
|
|
BBP
|
BioShares Biotechnology Products Fund
|
US
|
AMEX
|
|
BCDA
|
BioCardia, Inc.
|
US
|
NASDAQ
|
|
BCEL
|
Atreca, Inc.
|
US
|
NASDAQ
|
|
BCLI
|
Brainstorm Cell Therapeutics Inc.
|
US
|
NASDAQ
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BCTX
|
BriaCell Therapeutics Corp.
|
US
|
NASDAQ
|